<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35277093</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1521-0464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug delivery</Title>
          <ISOAbbreviation>Drug Deliv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics.</ArticleTitle>
        <Pagination>
          <StartPage>856</StartPage>
          <EndPage>870</EndPage>
          <MedlinePgn>856-870</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10717544.2022.2036870</ELocationID>
        <Abstract>
          <AbstractText>Berberine (BBR) has extremely low concentration and high tissue distribution. However, current pharmacokinetic studies predominantly focus on its concentration in plasma, which could hardly make a comprehensive understanding of its pharmacokinetic process. This study made a pioneering endeavor to explore the erythrocyte-hemoglobin (Hb) self-assembly system of BBR by exploring the interaction of BBR with erythrocyte and the combination of BBR with Hb. Results showed that BBR had a low bioavailability (<i>C<sub>0</sub></i> = 2.833 μg/mL via intravenous administration of 2.5 mg/kg BBR and <i>C<sub>max</sub></i> = 0.260 μg/mL via oral administration of 400 mg/kg BBR). Besides, BBR achieved higher concentrations in erythrocytes than plasma, and the erythrocytes count and Hb content were significantly decreased after intravenous administration. Hemolysis rate indicated the BBR-erythrocyte system (with 2% erythrocytes) was relatively stable without hemolysis at the concentration of 1.00 mg/mL. And the maximum percentage of drug loading was 100% when the BBR-erythrocyte concentration was 0.185 μg/mL. Furthermore, incubation of BBR and erythrocytes resulted in internalization of the erythrocyte membrane and the formation of intracellular vacuoles. The thermodynamic parameters indicated that the binding process of bovine hemoglobin (BHB) and BBR was spontaneous. UV-vis absorption spectra, synchronous fluorescence, circular dichroism and Raman spectra collectively indicated that BBR showed strong binding affinity toward BHB and affected the molecular environment of residues like tryptophan and tyrosine in BHB, resulting in the conformational changes of its secondary and tertiary structure. Molecular docking indicated BBR interacted with Arg-141 residue of BHB via hydrogen bond with the bond length of 2.55 Å. The ΔG value of the BHB-BBR system was -31.79 kJ/mol. Molecular dynamics simulation indicated the root mean square derivation of BBR-BHB was &lt;0.025 nm, suggestive of stable conformation. Cumulatively, there was an erythrocyte-Hb self-assembled drug delivery system after oral or intravenous administration of BBR, which conceivably gained novel insight into the discrepancy between the extremely low plasma concentration and relatively high tissue concentration of BBR.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Qiuxia</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>The Second Clinical College of Guangzhou, University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Minhua</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Hanbin</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>The First Affiliated Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Lieqiang</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Juanjuan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Guoshu</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yuhong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Su</LastName>
            <ForeName>Ziren</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Xiaobo</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yucui</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jiannan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Jianhui</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Drug Deliv</MedlineTA>
        <NlmUniqueID>9417471</NlmUniqueID>
        <ISSNLinking>1071-7544</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0I8Y3P32UF</RegistryNumber>
          <NameOfSubstance UI="D001599">Berberine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001599" MajorTopicYN="Y">Berberine</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001682" MajorTopicYN="N">Biological Availability</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Berberine</Keyword>
        <Keyword MajorTopicYN="N">erythrocyte</Keyword>
        <Keyword MajorTopicYN="N">hemoglobin</Keyword>
        <Keyword MajorTopicYN="N">pharmacokinetics</Keyword>
        <Keyword MajorTopicYN="N">self-assembly system</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the authors.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>12</Day>
          <Hour>5</Hour>
          <Minute>21</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35277093</ArticleId>
        <ArticleId IdType="pmc">PMC8920379</ArticleId>
        <ArticleId IdType="doi">10.1080/10717544.2022.2036870</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Allen TM, Cullis PR. (2004). Drug delivery systems: Entering the mainstream. Science
303:1818–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15031496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atkins CG, Buckley K, Blades MW, et al.  (2017). Raman Spectroscopy of blood and blood components. Appl Spectrosc
71:767–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28398071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao X, Zhu Z, Li NQ, et al.  (2001). Electrochemical studies of rutin interacting with hemoglobin and determination of hemoglobin. Talanta
54:591–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18968281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Basu A, Suresh Kumar G. (2015). Binding of carmoisine, a food colorant, with hemoglobin: spectroscopic and calorimetric studies. Food Res Int
72:54–61.</Citation>
        </Reference>
        <Reference>
          <Citation>Berikkhanova K, Omarbaev R, Gulyayev A, et al.  (2016). Red blood cell ghosts as promising drug carriers to target wound infections. Med Eng Phys
38:877–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27062487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borkar RM, Bhandi MM, Dubey AP, et al.  (2015). Plasma protein binding, pharmacokinetics, tissue distribution and CYP450 biotransformation studies of fidarestat by ultra high performance liquid chromatography-high resolution mass spectrometry. J Pharm Biomed Anal
102:386–99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25459938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai Z, Wang C, Yang W. (2016). Role of berberine in Alzheimer's disease. Neuropsychiatr Dis Treat
12:2509–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5055107</ArticleId>
            <ArticleId IdType="pubmed">27757035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen HB, Luo CD, Ai GX, et al.  (2021). A comparative investigation of the interaction and pharmacokinetics of hemoglobin with berberine and its oxymetabolite. J Pharm Biomed Anal
199:114032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33774454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W, Miao YQ, Fan DJ, et al.  (2011). Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. Aaps Pharmscitech
12:705–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3134654</ArticleId>
            <ArticleId IdType="pubmed">21637946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cicero AF, Baggioni A. (2016). Berberine and its role in chronic disease. Adv Exp Med Biol
928:27–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27671811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dou Y, Huang R, Li Q, et al.  (2021). Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways. Biomed Pharmacother
137:111312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33524788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dybas J, Chiura T, Marzec KM, Mak PJ. (2021). Probing heme active sites of hemoglobin in functional red blood cells using resonance Raman Spectroscopy. J Phys Chem B
125:3556–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8154613</ArticleId>
            <ArticleId IdType="pubmed">33787265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan NC, Cheng FY, Ho JA, et al.  (2012a). Photocontrolled targeted drug delivery: photocaged biologically active folic acid as a light-responsive tumor-targeting molecule. Angew Chem Int Ed Engl
51:8806–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22833461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan W, Yan W, Xu Z, et al.  (2012b). Erythrocytes load of low molecular weight chitosan nanoparticles as a potential vascular drug delivery system. Colloids Surf B Biointerfaces
95:258–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22469561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng X, Sureda A, Jafari S, et al.  (2019). Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics
9:1923–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6485276</ArticleId>
            <ArticleId IdType="pubmed">31037148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandes HP, Cesar CL, Barjas-Castro Mde L. (2011). Electrical properties of the red blood cell membrane and immunohematological investigation. Rev Bras Hematol Hemoter
33:297–301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3415751</ArticleId>
            <ArticleId IdType="pubmed">23049321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fontes A, Fernandes HP, de Thomaz AA, et al.  (2008). Measuring electrical and mechanical properties of red blood cells with double optical tweezers. J Biomed Opt
13:014001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18315359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu K, Wang Z, Cao R. (2021). Berberine attenuates the inflammatory response by activating the Keap1/Nrf2 signaling pathway in bovine endometrial epithelial cells. Int Immunopharmacol
96:107738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33984720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gong Z, Chen Y, Zhang R, et al.  (2014). Pharmacokinetic comparison of berberine in rat plasma after oral administration of berberine hydrochloride in normal and post inflammation irritable bowel syndrome rats. Int J Mol Sci
15:456–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3907819</ArticleId>
            <ArticleId IdType="pubmed">24451127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu S, Song X, Xie R, et al.  (2020). Berberine inhibits cancer cells growth by suppressing fatty acid synthesis and biogenesis of extracellular vesicles. Life Sci
257:118122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32702446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamidi M, Zarrin A, Foroozesh M, et al.  (2007). Applications of carrier erythrocytes in delivery of biopharmaceuticals. J Control Release
118:145–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17270305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harisa G. E-d I, Ibrahim MF, Alanazi FK. (2011). Characterization of human erythrocytes as potential carrier for pravastatin: an in vitro study. Int J Med Sci
8:222–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3065791</ArticleId>
            <ArticleId IdType="pubmed">21448309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hazra S, Hossain M, Suresh Kumar G. (2013). Binding of isoquinoline alkaloids berberine, palmatine and coralyne to hemoglobin: structural and thermodynamic characterization studies. Mol Biosyst
9:143–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23147244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hou Q, He W-J, Wu Y-S, et al.  (2020). Berberine: a traditional natural product with novel biological activities. Altern Ther Health Med
26:20–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31634873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua W, Ding L, Chen Y, et al.  (2007). Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry. J Pharm Biomed Anal
44:931–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17531424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JBF L. (1971). Synchronized excitation of fluorescence emission spectra. Cell Rep Phys Sci 231:64–5.</Citation>
        </Reference>
        <Reference>
          <Citation>Keene WR, Jandl JH. (1965). The sites of hemoglobin catabolism. Blood
26:705–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5844144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan AY, Hossain M, Kumar GS. (2013). Binding of plant alkaloids berberine and palmatine to serum albumins: a thermodynamic investigation. Mol Biol Rep
40:553–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23065224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan AY, Kumar GS. (2016). Probing the binding of anticancer drug topotecan with human hemoglobin: structural and thermodynamic studies. J Photochem Photobiol B
163:185–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27585365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klajnert B, Bryszewska M. (2002). Fluorescence studies on PAMAM dendrimers interactions with bovine serum albumin. Bioelectrochemistry
55:33–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11786335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klatt S, Roberts A, Lothian A, et al.  (2020). Optimizing red blood cell protein extraction for biomarker quantitation with mass spectrometry. Anal Bioanal Chem
412:1879–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32030493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klei TR, Meinderts SM, van den Berg TK, et al.  (2017). From the cradle to the grave: the role of macrophages in erythropoiesis and erythrophagocytosis. Front Immunol
8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5288342</ArticleId>
            <ArticleId IdType="pubmed">28210260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koleva L, Bovt E, Ataullakhanov F, et al.  (2020). Erythrocytes as carriers: from drug delivery to biosensors. Pharmaceutics
12:276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7151026</ArticleId>
            <ArticleId IdType="pubmed">32197542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kostjukova LO, Kostjukov VV. (2021). The electronic states and vibronic absorption spectrum of berberine in aqueous solution. Int J Quantum Chem
121:e26537.</Citation>
        </Reference>
        <Reference>
          <Citation>Lau CW, Yao XQ, Chen ZY, et al.  (2001). Cardiovascular actions of berberine. Cardiovasc Drug Rev
19:234–44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11607041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee SJ, Park SY, Jung MY, et al.  (2011). Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver. Blood
117:5215–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21427291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lemler P, Premasiri WR, DelMonaco A, et al.  (2014). NIR Raman spectra of whole human blood: effects of laser-induced and in vitro hemoglobin denaturation. Anal Bioanal Chem
406:193–200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3882123</ArticleId>
            <ArticleId IdType="pubmed">24162820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li C, Ai G, Wang Y, et al.  (2020). Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway. Pharmacol Res
152:104603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31863867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li CL, Tan LH, Wang YF, et al.  (2019). Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo. Phytomedicine
52:272–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30599908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li QP, Dou YX, Huang ZW, et al.  (2021). Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats. Phytomedicine
85:153550.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33831691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Liu XG, Wang HY, et al.  (2016). Pharmacokinetic studies of phellodendrine in rat plasma and tissues after intravenous administration using ultra-high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci
1029-1030:95–101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27428451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu CS, Zheng YR, Zhang YF, et al.  (2016). Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia
109:274–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26851175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu YT, Hao HP, Xie HG, et al.  (2010). Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos
38:1779–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20634337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li XY, Roman S, Czernuszewicz  , et. Al. (1990). Consistent porphyrin force field. 2. Nickel octaethylporphyrin skeletal and substituent mode assignments from 15N, meso-d4, and methylene-d16 Raman and infrared isotope shifts. J Phys Chem
94: 1.</Citation>
        </Reference>
        <Reference>
          <Citation>Lu JQ, Jin F, Sun TQ, et al.  (2007). Multi-spectroscopic study on interaction of bovine serum albumin with lomefloxacin-copper(II) complex. Int J Biol Macromol
40:299–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17030362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagai M, Mizusawa N, Kitagawa T, et al.  (2018). A role of heme side-chains of human hemoglobin in its function revealed by circular dichroism and resonance Raman spectroscopy. Biophys Rev
10:271–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5899723</ArticleId>
            <ArticleId IdType="pubmed">29260461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagel RL, Gibson QH. (1971). The binding of hemoglobin to haptoglobin and its relation to subunit dissociation of hemoglobin. J Biol Chem
246:69–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5541775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ortiz LM, Lombardi P, Tillhon M, et al.  (2014). Berberine, an epiphany against cancer. Molecules
19:12349–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6271598</ArticleId>
            <ArticleId IdType="pubmed">25153862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel P. (2021). A bird's eye view on a therapeutically ‘wonder molecule’: berberine. Phytomed Plus
1:100070.</Citation>
        </Reference>
        <Reference>
          <Citation>Patil S, Sandberg A, Heckert E, et al.  (2007). Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials
28:4600–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2259388</ArticleId>
            <ArticleId IdType="pubmed">17675227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pierigè F, Bigini N, Rossi L, et al.  (2017). Reengineering red blood cells for cellular therapeutics and diagnostics. Wires
9:e1454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28116852</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romański M, Zacharzewska A, Teżyk A, et al.  (2018). In vivo red blood cells/plasma partition coefficient of treosulfan and its active monoepoxide in rats. Eur J Drug Metab Pharmacokinet
43:565–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6133075</ArticleId>
            <ArticleId IdType="pubmed">29542019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross PD, Subramanian S. (1981). Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry
20:3096–102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7248271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scarlett G, Siligardi G, Kneale GG. (2015). Circular dichroism for the analysis of protein-DNA interactions. Methods Mol Biol
1334:299–312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26404158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt S, Gonzalez D, Derendorf H. (2010). Significance of protein binding in pharmacokinetics and pharmacodynamics. J Pharm Sci
99:1107–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19852037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen XC, Liou XY, Ye PL, et al.  (2007). Spectroscopic studies on the interaction between human hemoglobin and CdS quantum dots. J Colloid Interface Sci
311:400–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17433354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ship NJ, Toprak A, Lai RP, et al.  (2005). Binding of acellular, native and cross-linked human hemoglobins to haptoglobin: enhanced distribution and clearance in the rat. Am J Physiol Gastrointest Liver Physiol
288:G1301–G1309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15890714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shobini J, Mishra AK, Sandhya K, et al.  (2001). Interaction of coumarin derivatives with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies. Spectrochim Acta A Mol Biomol Spectrosc
57:1133–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11374572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singhal R, Chawla S, Rathore DK, et al.  (2017). Development of pro-inflammatory phenotype in monocytes after engulfing Hb-activated platelets in hemolytic disorders. Clin Immunol
175:133–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28039017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sousa T, Paterson R, Moore V, et al.  (2008). The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm
363:1–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18682282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spiro TG. (1985). Resonance Raman spectroscopy as a probe of heme protein structure and dynamics. Adv Protein Chem
37:111–59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2998161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun Y, Wang W, Tong Y. (2019). Berberine inhibits proliferative ability of breast cancer cells by reducing metadherin. Med Sci Monit
25:9058–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6900918</ArticleId>
            <ArticleId IdType="pubmed">31779025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szumiło M. (2013). Erythrocytes - the new application in medicine. Pol Merkur Lekarski
34:5–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23488276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan XS, Ma JY, Feng R, et al.  (2013). Tissue distribution of berberine and its metabolites after oral administration in rats. PLOS One
8:e77969.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3815028</ArticleId>
            <ArticleId IdType="pubmed">24205048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Theurl I, Hilgendorf I, Nairz M, et al.  (2016). On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nat Med
22:945–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4957133</ArticleId>
            <ArticleId IdType="pubmed">27428900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venkatesh B, Ramasamy S, Mylrajan M, et al.  (1999). Fourier transform Raman approach to structural correlation in hemoglobin derivatives. S Spectrochim Acta A Mol Biomol Spectrosc
55:1691–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10439514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vos FE, Schollum JB, Coulter CV, et al.  (2011). Red blood cell survival in long-term dialysis patients. Am J Kidney Dis
58:591–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21715072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C, Perumalla SR, Lu J, et al.  (2016). Sweet berberine. Crystal Growth &amp; Design
16:933–9.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang YQ, Zhang HM, Zhang GC, et al.  (2007). Studies of the interaction between paraquat and bovine hemoglobin. Int J Biol Macromol
41:243–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17403534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wood BR, Caspers P, Puppels GJ, et al.  (2007). Resonance Raman spectroscopy of red blood cells using near-infrared laser excitation. Anal Bioanal Chem
387:1691–703.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17151857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woody RW. (1995). Circular-dichroism. In: Sauer K., editor, Biochemical spectroscopy. Methods enzymol
246:34–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7538625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu T, Wu Q, Guan S, et al.  (2007). Binding of the environmental pollutant naphthol to bovine serum albumin. Biomacromolecules
8:1899–906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17407349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu L, Lin G, Yu Q, et al.  (2021). Anti-hyperuricemic and nephroprotective effects of dihydroberberine in potassium oxonate- and hypoxanthine-induced hyperuricemic mice. Front Pharmacol
12:645879.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8093860</ArticleId>
            <ArticleId IdType="pubmed">33959014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan QN, Zhang S, Zhang ZQ. (2009). Study on the tissue distribution of berberine from Rhizoma Coptidis and compatibility with Rhizoma Coptidis and Cortex Cinnamomi in rats. Zhong Yao Cai
32:575–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19645246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Q, Liang J, Han H. (2009). Probing the interaction of magnetic iron oxide nanoparticles with bovine serum albumin by spectroscopic techniques. J Phys Chem B
113:10454–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19583232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin WY, Yuan J, Zhang ZM, et al.  (2021). 18F-fluorodeoxyglucose positron emission tomography-computed tomography for assessing organ distribution of stressed red blood cells in mice. Sci Rep
11:2505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7844045</ArticleId>
            <ArticleId IdType="pubmed">33510312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu F, Ao M, Zheng X, et al.  (2017). PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency. Drug Deliv
24:825–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8241132</ArticleId>
            <ArticleId IdType="pubmed">28509588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang K, Mao L, Cai R. (2000). Stopped-flow spectrophotometric determination of hydrogen peroxide with hemoglobin as catalyst. Talanta
51:179–86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18967850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang N, Palmer AF. (2011). Development of a dichloroacetic acid-hemoglobin conjugate as a potential targeted anti-cancer therapeutic. Biotechnol Bioeng
108:1413–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21328317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zou K, Li Z, Zhang Y, et al.  (2017). Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol Sin
38:157–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5309756</ArticleId>
            <ArticleId IdType="pubmed">27917872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zuo F, Nakamura N, Akao T, et al.  (2006). Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metab Dispos
34:2064–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16956957</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
